"Item Id","Item URI","Dublin Core:Title","Dublin Core:Subject","Dublin Core:Description","Dublin Core:Creator","Dublin Core:Source","Dublin Core:Publisher","Dublin Core:Date","Dublin Core:Contributor","Dublin Core:Rights","Dublin Core:Relation","Dublin Core:Format","Dublin Core:Language","Dublin Core:Type","Dublin Core:Identifier","Dublin Core:Coverage","Item Type Metadata:Bibliography","Item Type Metadata:Biographical Text","Item Type Metadata:Occupation","Item Type Metadata:Death Date","Item Type Metadata:Birthplace","Item Type Metadata:Text","Item Type Metadata:Player","Item Type Metadata:Access","Item Type Metadata:Alternate URL","Item Type Metadata:Citation","Item Type Metadata:Accessibility","Item Type Metadata:Abstract","Item Type Metadata:Read Online","Item Type Metadata:Additional Exercise","Item Type Metadata:Email Body","Item Type Metadata:Interviewer","Item Type Metadata:Interviewee","Item Type Metadata:Location","Item Type Metadata:Transcription","Item Type Metadata:Local URL","Item Type Metadata:Original Format","Item Type Metadata:Physical Dimensions","Item Type Metadata:Duration","Item Type Metadata:Compression","Item Type Metadata:Producer","Item Type Metadata:Director","Item Type Metadata:Bit Rate/Frequency","Item Type Metadata:Time Summary","Item Type Metadata:Birth Date","Item Type Metadata:Subject Line","Item Type Metadata:From","Item Type Metadata:To","Item Type Metadata:CC","Item Type Metadata:BCC","Item Type Metadata:Number of Attachments","Item Type Metadata:Standards","Item Type Metadata:Objectives","Item Type Metadata:Materials","Item Type Metadata:Lesson Plan Text","Item Type Metadata:URL","Item Type Metadata:Event Type","Item Type Metadata:Participants","PDF Text:Text",tags,file,itemType,collection,public,featured
1788,https://repository.netecweb.org/items/show/1788,"Nipah virus, an emerging zoonotic disease causing fatal encephalitis","Infection Control","Nipah virus is an acute febrile illness that can cause fatal encephalitis. It is an emerging zoonotic paramyxovirus endemic to south-east Asia and the western Pacific, and can be transmitted by its primary reservoir of fruit bats, through intermediate animal vectors and by human-to-human spread.","Ali M Alam.",,,2022-07-22,,,,,,Publication,,2024-10-03,,,,,,,,,,"Alam AM. Nipah virus, an emerging zoonotic disease causing fatal encephalitis. Clin Med (Lond). 2022 Jul;22(4):348-352. doi: 10.7861/clinmed.2022-0166. Epub 2022 Jun 27. PMID: 35760448; PMCID: PMC9345211.","Free online on PubMed Central.","
Nipah virus is an acute febrile illness that can cause fatal encephalitis. It is an emerging zoonotic paramyxovirus endemic to south-east Asia and the western Pacific, and can be transmitted by its primary reservoir of fruit bats, through intermediate animal vectors and by human-to-human spread. Outbreaks of Nipah virus encephalitis have occurred in Malaysia, Singapore, Philippines, India and Bangladesh, with the most recent outbreak occurring in Kerala, India in late 2021. Extremely high case fatality rates have been reported from these outbreaks, and to date no vaccines or therapeutic management options are available. Combining this with its propensity to present non-specifically, Nipah virus encephalitis presents a challenging diagnosis that should not be missed in patients returning from endemic regions. Raising awareness of the epidemiology, clinical presentation and risk factors of contracting Nipah virus is vital to recognise and manage potential outbreaks of this disease in the UK.
KEYWORDS: Nipah virus, encephalitis, emerging diseases, zoonotic disease, tropical medicine
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345211/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35760448/,,,,"Nipah (NiV),R-IPC,Zoonotic",,Publication,Discover,1,0
1787,https://repository.netecweb.org/items/show/1787,"Recent advances in combating Nipah virus","Infection Control","Over the past 20 years, Nipah virus (NiV) has emerged as a significant, highly pathogenic bat-borne paramyxovirus causing severe respiratory disease and encephalitis in humans, and human-to-human transmission has been demonstrated in multiple outbreaks.","Kendra Johnson, Michelle Vu, and Alexander N Freiberg.",,,2021-09-29,,,,,,Publication,,2024-10-03,,,,,,,,,,"Johnson K, Vu M, Freiberg AN. Recent advances in combating Nipah virus. Fac Rev. 2021 Sep 29;10:74. doi: 10.12703/r/10-74. PMID: 34632460; PMCID: PMC8483238.","Free online on PubMed Central.","
Over the past 20 years, Nipah virus (NiV) has emerged as a significant, highly pathogenic bat-borne paramyxovirus causing severe respiratory disease and encephalitis in humans, and human-to-human transmission has been demonstrated in multiple outbreaks. In addition to causing serious illness in humans, NiV is a zoonotic pathogen capable of infecting a wide range of other mammalian species, including pigs and horses. While NiV has caused less than 700 human cases since its discovery in 1998/1999, the involvement of intermediate agricultural hosts can result in significant economic consequences. Owing to the severity of disease, capacity for human-to-human transmission, zoonotic potential, and lack of available approved therapeutic treatment options, NiV has been listed by the World Health Organization in their Blueprint list of priority pathogens as one of the eight most dangerous pathogens to monitor and prepare countermeasures to prevent a pandemic. Here, we discuss progress towards the development of therapeutic measures for the treatment of NiV infection and disease.
Keywords: Nipah virus, henipavirus, respiratory disease, encephalitis, antivirals, antibodies
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483238/,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/34632460/,,,,"Nipah (NiV),R-IPC,Respiratory Pathogen,Zoonotic",,Publication,Discover,1,0
1607,https://repository.netecweb.org/items/show/1607,"Marburg virus disease Fact Sheet",General,"This WHO fact sheet covers Marburg virus disease:
- Key facts
- Transmission
- Symptoms of Marburg virus disease
- Diagnosis
- Treatment and vaccines
- Marburg virus in animals
- Prevention and control
- Controlling infection in healthcare settings
- Marburg viral persistence in in people recovering from Marburg virus disease
- WHO response
",WHO,,,2021-08-07,"2022-12-07 general asset review - IPC
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q2)",,"Y
Y - D0.1IC/D0.2IC Qualtrics # 231, original # 17a (additional resources)",,,,"Infection Prevention and Control",2024-12-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease,,,,"Contact Transmission,Diagnosis,Infection Prevention and Control,Marburg,Occupational Exposure,Occupational Health,Outcomes,R-IPC,R-PM,Treatment and Care,Viral Hemorrhagic Fever,Zoonotic",https://repository.netecweb.org/files/original/25dd695aa15a518fd2e0f8920c770faa.png,Hyperlink,Discover,1,0
1267,https://repository.netecweb.org/items/show/1267,"Transmission of SARS-CoV-2 in Domestic Cats",Research,"Reports of human-to-feline transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of limited airborne transmission among cats prompted us to evaluate nasal shedding of SARS-CoV-2 from inoculated cats and the subsequent transmission of the virus by direct contact between virus-inoculated cats and cats with no previous infection with the virus.","Halfmann, Peter J., Masato Hatta, Shiho Chiba, Tadashi Maemura, Shufang Fan, Makoto Takeda, Noriko Kinoshita, Shin-ichiro Hattori, Yuko Sakai-Tagawa, Kiyoko Iwatsuki-Horimoto, Masaki Imai, and Yoshihiro Kawaoka.",,,2020-08-06,,,,,,Publication,,,,,,,,,,,,"Halfmann, Peter J., Masato Hatta, Shiho Chiba, Tadashi Maemura, Shufang Fan, Makoto Takeda, Noriko Kinoshita, Shin-ichiro Hattori, Yuko Sakai-Tagawa, Kiyoko Iwatsuki-Horimoto, Masaki Imai, and Yoshihiro Kawaoka. 2020. ""Transmission of SARS-CoV-2 in Domestic Cats."" New England Journal of Medicine 383 (6):592-4.
","Free online on NEJM",,https://www.nejm.org/doi/full/10.1056/NEJMc2013400,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.nejm.org/doi/full/10.1056/NEJMc2013400,,,,"2019-nCoV,Airborne Transmission,Coronavirus,COVID-19,Droplet Transmission,Pets,R-Res&Pub,Research,Zoonotic",,Publication,Discover,1,0
776,https://repository.netecweb.org/items/show/776,"Update on Ebola Treatment Center Costs and Sustainability, United States, 2019","Physical Infrastructure","We surveyed 56 Ebola treatment centers (ETCs) in the United States and identified costs incurred since 2014 ($1.76 million/ETC) and sustainability strategies.","Herstein, Jocelyn J., Aurora B. Le, Lily A. McNulty, Sean A. Buehler, Paul D. Biddinger, Angela L. Hewlett, John J. Lowe, and Shawn G. Gibbs.",,,2020-05-17,"2023-08-31 by Shawn Gibbs - PhysInfr General Review - COI Gibbs co-author",,,,,Publication,,2026-08-31,,,,,,,,,,"Herstein, Jocelyn J., Aurora B. Le, Lily A. McNulty, Sean A. Buehler, Paul D. Biddinger, Angela L. Hewlett, John J. Lowe, and Shawn G. Gibbs. 2020. ""Update on Ebola Treatment Center Costs and Sustainability, United States, 2019."" Emerging infectious diseases 26 (5):10.3201/eid2605.191245.
","Free online","
We surveyed 56 Ebola treatment centers (ETCs) in the United States and identified costs incurred since 2014 ($1.76 million/ETC) and sustainability strategies. ETCs reported heavy reliance on federal funding. It is uncertain if, or for how long, ETCs can maintain capabilities should federal funding expire in 2020.
KEYWORDS:
Ebola; Ebola treatment centers; Ebola virus disease; Ebolavirus; United States; communicable diseases; costs; emerging; hospitals; isolation; sustainability; viruses; zoonoses
",https://wwwnc.cdc.gov/eid/article/26/5/19-1245_article,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32097110,,,,"Ebola,Example,Isolate,Isolation/Biocontainment,Physical Infrastructure,R-Lead,R-PhIn,R-Res&Pub,Special Pathogens,Treatment Facility,Zoonotic",,Publication,Discover,1,0
741,https://repository.netecweb.org/items/show/741,"Game consumption and the 2019 novel coronavirus",Research,"In December, 2019, the 2019 novel coronavirus (2019-nCoV) infecting humans was first identified in Wuhan, China.","Li, Jie, Jun Li, Xiaoru Xie, Xiaomei Cai, Jian Huang, Xuemei Tian, and Hong Zhu.",,,2020-02-07,,,,,,Publication,,,,,,,,,,,,"Li, Jie, Jun Li, Xiaoru Xie, Xiaomei Cai, Jian Huang, Xuemei Tian, and Hong Zhu. 2020. ""Game consumption and the 2019 novel coronavirus."" The Lancet Infectious Diseases 20 (3):275-6.
","Free online on Lancet site.",,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30063-3/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30063-3/fulltext,,,,"2019-nCoV,Coronavirus,COVID-19,R-Res&Pub,Zoonotic",,Publication,Discover,1,0
673,https://repository.netecweb.org/items/show/673,"Another Decade, Another Coronavirus",General,"For the third time in as many decades, a zoonotic coronavirus has crossed species to infect human populations. This virus, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market.","Stanley Perlman",,,2020-01-24,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,Publication,,2025-01-01,,,,,,,,,,"Perlman, Stanley. 2020. ""Another Decade, Another Coronavirus."" New England Journal of Medicine.","Free on journal website",,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.nejm.org/doi/full/10.1056/NEJMe2001126,,,,"Coronavirus,COVID-19,Diagnosis,MERS-CoV,R-Gen,R-Res&Pub,SARS,Zoonotic",,Publication,Discover,1,0
565,https://repository.netecweb.org/items/show/565,"MERS-CoV: public health investigation and management of possible cases: Investigation and public health management of possible cases of Middle East respiratory syndrome coronavirus (MERS-CoV)","Infection Control","Algorithm on public health investigation and management of possible cases of MERS-CoV (Middle East respiratory syndrome coronavirus).","United Kingdom Department of Health (DH)",,,2018-08-07,"2022-12-07 general asset review - IPC (move to R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,"Adult Care",2024-06-10,,,,,,,,,,"© Crown copyright 2018, Open Government Licence v3.0",,,,,,,,,,,,,,,,,,,,,,,,,,,"Details
The incubation period for Middle East respiratory syndrome coronavirus (MERS-CoV) is currently considered to be up to 14 days. Any respiratory illness occurring in the 14 days following last contact with a confirmed case of MERS-CoV is considered relevant.
Close contacts should self-isolate and alert their GP as soon as possible: where the close contacts are healthcare workers this should be their manager or occupational health service. Symptoms would include fever, cough, or any other respiratory symptoms.
",,,https://www.gov.uk/government/publications/mers-cov-public-health-investigation-and-management-of-possible-cases,,,,"Coronavirus,MERS-CoV,Procedure,Protocol,R-T&C,Respiratory Pathogen,Zoonotic",https://repository.netecweb.org/files/original/a1bf6645c4fa26cf44ee390d88ed849c.pdf,Guide,Discover,1,0
564,https://repository.netecweb.org/items/show/564,"Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), 22nd update","Infection Control","This update of ECDC’s risk assessment on MERS-CoV was triggered by the detection of a case imported into the EU/EEA from the Kingdom of Saudi Arabia (KSA). In this update, we reassess the risk for EU/EEA residents. ","European Union, European Centre for Disease Prevention and Control (ECDC)",,,2018-08-29,"2022-12-07 general asset review - IPC (move to R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,"Adult Care",2024-06-10,,,,,,,,,,"European Centre for Disease Prevention and Control. Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). 22nd update, 29 August 2018. Stockholm: ECDC, 2018. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-severe-respiratory-disease-associated-middle-east-11,,,,"Coronavirus,MERS-CoV,R-T&C,Respiratory Pathogen,Zoonotic",https://repository.netecweb.org/files/original/b06bbc31300b24e911d386d0464db5df.png,Guide,Discover,1,0
563,https://repository.netecweb.org/items/show/563,"MERS-CoV: Clinical Management and Guidance","Infection Control","Guidance on investigating Middle East respiratory syndrome coronavirus (MERS-CoV), public health management of suspected UK cases and advice to travellers.","United Kingdom Department of Health (DH)",,,2018-09-20,"2022-12-07 general asset review - IPC (move to R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,,"Adult Care",2024-06-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"This site contains guides for Diagnosis and Public health management.",,,https://www.gov.uk/government/collections/middle-east-respiratory-syndrome-coronavirus-mers-cov-clinical-management-and-guidance,,,,"Coronavirus,Diagnosis,MERS-CoV,Public Health,R-T&C,Respiratory Pathogen,Zoonotic",https://repository.netecweb.org/files/original/2617c610b8b60d8a935777780d7d8189.png,Guide,Discover,1,0
562,https://repository.netecweb.org/items/show/562,"Data sharing in public health emergencies: Analysis of barriers and enablers from an outbreak response perspective (SHARE)",Research,"Timely access to data during infectious disease outbreaks by those involved in research preparedness and response provides essential input for public health response and for outbreak-related research. ","Wellcome Trust","Martine van Roode, Carolina dos Santos Ribeiro, Elmoubasher Farag, Minahil Ahmed, Aya Moustafa, Linda van de Burgwal, Eric Claassen, Mohammed Nour, George Haringhuizen, Marion Koopmans.",,2018-12,,,,,,Publication,,,,,,,,,,,,"Martine van Roode, Carolina dos Santos Ribeiro, Elmoubasher Farag, Minahil Ahmed, Aya Moustafa, Linda van de Burgwal, Eric Claassen, Mohammed Nour, George Haringhuizen, Marion Koopmans. 2018. Data sharing in public health emergencies: Analysis of barriers and enablers from an outbreak response perspective (SHARE): The case of Middle East Respiratory Syndrome (MERS). Wellcome Trust.","Free Online","Timely access to data during infectious disease outbreaks by those involved in research preparedness and response provides essential input for public health response and for outbreak-related research. ",http://www.glopid-r.org/wp-content/uploads/2019/07/SHARE-MERS-CoV-case-study-report-final-1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,https://wellcome.ac.uk/what-we-do/our-work/data-sharing-public-health-emergencies,,,,"Communications,Coronavirus,MERS-CoV,R-Res&Pub,Respiratory Pathogen,Zoonotic",,Publication,Discover,1,0
561,https://repository.netecweb.org/items/show/561,"Assessment of potential risk factors of Middle East respiratory syndrome coronavirus (MERS-CoV) infection among health care personnel in a health care setting","Infection Control","Protocol for MERS-CoV: This protocol outlines methods of an analytical epidemiological, virological and serological study involving staff working at a health care facility(ies) where an index patient infected with MERS-CoV virus is currently being or has been treated. (WHO)",WHO,,,2019-01,"2022-12-07 general asset review - IPC (move to R-T&C)
2024-03-28 by J. Mundy – IPC review 2023 (Q2) skipped – bumping to 2024 (Q4)",,,,,Publication,"Adult Care",2024-06-10,,,,,,,,,,,"Free Online; Copyright WHO, CC-BY-NC-SA 4.0",,,,,,,,,,,,,,,,,,,,,,,,,,"Using a standardized protocol such as the protocol described below, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally. This is particularly important in the context of a novel respiratory pathogen. (WHO)",,,https://www.who.int/publications/m/item/assessment-of-potential-risk-factors-of-middle-east-respiratory-syndrome-coronavirus-(mers-cov)-infection-among-health-care-personnel-in-a-health-care-setting,,,,"Coronavirus,Infection Prevention and Control,MERS-CoV,Occupational Exposure,Occupational Health,R-Res&Pub,R-T&C,Respiratory Pathogen,Zoonotic",https://repository.netecweb.org/files/original/bbc281f6e67cc06f35a852f1f47c5ea0.docx,Protocol,Discover,1,0
560,https://repository.netecweb.org/items/show/560,"Prise en charge clinique des infections respiratoires aiguës sévères lorsqu’une infection par le coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) est soupçonnée - Lignes directrices provisoires ","Contenu Français","Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected - Interim guidance - in French.",WHO,,,2015-07,,,,,,Publication,,,,,,,,,,,,"Organisation mondiale de la Santé. (2015). Prise en charge clinique des infections respiratoires aiguës sévères lorsqu’une infection par le coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) est soupçonnée : lignes directrices provisoires. Organisation mondiale de la Santé. https://apps.who.int/iris/handle/10665/186680 ","Free Online, © Organisation mondiale de la Santé 2015",,https://apps.who.int/iris/handle/10665/186680,,,,,,,,,,,,,,,,,,,,,,,,,,,https://apps.who.int/iris/handle/10665/186680,,,,"Coronavirus,MERS-CoV,R-Res&Pub,Respiratory Pathogen,Zoonotic",,Publication,,1,0
559,https://repository.netecweb.org/items/show/559,"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected - Interim guidance","Treatment & Care","Overview
This document is intended for clinicians taking care of critically ill patients (adults and children) with severe acute respiratory infection (SARI).
",WHO,,,2019-01,"2022-09-27 - general asset review - Treatment & Care group",,,,,Publication,,2025-09-27,,,,,,,,,,"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance, Updated January 2019 (WHO/MERS/Clinical/15.1Revision 1). Geneva, Switzerland: World Health Organization; 2019. License: CCBY-NC-SA3.0IGO.","Free Online; License: CC BY-NC-SA 3.0IGO.",,https://apps.who.int/iris/handle/10665/178529,,,,,,,,,,,,,,,,,,,,,,,,,,,https://apps.who.int/iris/handle/10665/178529,,,,"Coronavirus,MERS-CoV,R-Res&Pub,R-T&C,Respiratory Pathogen,Zoonotic",https://repository.netecweb.org/files/original/663e6f1c530303b92288dedd0a38a902.pdf,Publication,Discover,1,0
558,https://repository.netecweb.org/items/show/558,"Frequently asked questions on Middle East respiratory syndrome coronavirus (MERS‐CoV)",General,"MERS-Cov FAQ",WHO,,,2019-01-21,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/news-room/questions-and-answers/item/middle-east-respiratory-syndrome-coronavirus-(mers-cov),,,,"Coronavirus,MERS-CoV,R-Gen,Respiratory Pathogen,Zoonotic",,Guide,Discover,1,0
557,https://repository.netecweb.org/items/show/557,"Middle East respiratory syndrome coronavirus (MERS-CoV) Fact Sheet",General,"MERS-CoV Fact Sheet",WHO,,,2019-03-11,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov),,,,"Coronavirus,MERS-CoV,R-Gen,Respiratory Pathogen,Zoonotic",,Guide,Discover,1,0
328,https://repository.netecweb.org/items/show/328,"National Center for Emerging and Zoonotic Infectious Diseases Strategic Plan: 2018-2023 ",General,"This document is a strategic roadmap for the work necessary to realize the center’s vision: prevent infections, protect people, and save lives. (CDC)","CDC, Office of Infectious Diseases (CDC OID)",,,2018-08,"2024-03-28 by J. Mundy – General subject – setting first review day 2025-01-01",,,,,,,2025-01-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/ncezid/pdf/ncezid-strategic-plan-2018-2023-508.pdf,,,,"Epidemic,Epidemiology,Federal,Outbreaks,Public Health,R-Gen,Special Pathogens,Zoonotic",https://repository.netecweb.org/files/original/45e9d41c887cd61b7f8b5ef3a3b82630.pdf,Guide,Discover,1,0
317,https://repository.netecweb.org/items/show/317,"Ecology of Emerging Zoonotic Diseases",General,"This webinar discusses Nipah virus and Ebola in terms of how human activity increases contact with wildlife and thus zoonotic disease emergence, and discusses interventions that reduce such risk.","CDC, Office of Public Health Preparedness and Response (CDC OPHPR)",,,2017-11-02,"2022-03-17 by Anna Yaffee (Adult Care Group) keep in Resource Library
2023-02-19 by Anna Yaffee T&C group Q1 review",,,,,,,2026-02-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://emergency.cdc.gov/coca/calls/2017/callinfo_110217.asp,,,,"Avian Influenza,Coronavirus,Crimean Congo Haemorrhagic Fever (CCHF),Ebola,Epidemic,Lassa,Marburg,Nipah (NiV),Outbreaks,Pandemic,Public Health,R-Gen,Respiratory Pathogen,SARS,Special Pathogens,Viral Hemorrhagic Fever,Zoonotic",https://repository.netecweb.org/files/original/42cc1379f3523ef4c23835c9b4049a9b.png,Webinar,Discover,1,0